Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.46 USD | +1.79% | -0.21% | -4.39% |
Dec. 13 | Turning Point Shares After $100 Million Share Offering Announced | MT |
Nov. 14 | Oppenheimer Initiates Turning Point Brands at Outperform With $65 Price Target | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 362M | 405M | 445M | 415M | 405M | |||||
Total Revenues | 362M | 405M | 445M | 415M | 405M | |||||
Cost of Goods Sold, Total | 202M | 215M | 228M | 209M | 202M | |||||
Gross Profit | 160M | 190M | 218M | 206M | 203M | |||||
Selling General & Admin Expenses, Total | 104M | 122M | 124M | 125M | 123M | |||||
R&D Expenses | 2.5M | 1.3M | 1.1M | 600K | 600K | |||||
Other Operating Expenses | - | - | - | - | -4.34M | |||||
Other Operating Expenses, Total | 106M | 123M | 125M | 126M | 119M | |||||
Operating Income | 53.42M | 66.69M | 92.39M | 79.76M | 84.31M | |||||
Interest Expense, Total | -17.34M | -20.23M | -20.5M | -19.52M | -15.81M | |||||
Interest And Investment Income | 2.65M | 198K | - | - | - | |||||
Net Interest Expenses | -14.69M | -20.03M | -20.5M | -19.52M | -15.81M | |||||
EBT, Excl. Unusual Items | 38.73M | 46.66M | 71.89M | 60.24M | 68.5M | |||||
Restructuring Charges | -26.2M | - | -800K | -3.44M | -400K | |||||
Merger & Related Restructuring Charges | - | -3.09M | -1.27M | -801K | -165K | |||||
Impairment of Goodwill | - | - | - | -25.58M | - | |||||
Gain (Loss) On Sale Of Investments | - | - | -6.67M | -13.3M | -11.91M | |||||
Asset Writedown | - | - | - | -1.98M | - | |||||
Insurance Settlements | - | - | - | - | 15.2M | |||||
Legal Settlements | 5.5M | - | - | - | 4M | |||||
Other Unusual Items | -2.21M | -517K | 2.15M | 885K | -13.54M | |||||
EBT, Incl. Unusual Items | 15.82M | 43.06M | 65.3M | 16.01M | 61.68M | |||||
Income Tax Expense | 2.04M | 10.02M | 14.04M | 4.85M | 23.9M | |||||
Earnings From Continuing Operations | 13.77M | 33.04M | 51.26M | 11.16M | 37.78M | |||||
Net Income to Company | 13.77M | 33.04M | 51.26M | 11.16M | 37.78M | |||||
Minority Interest | - | - | 797K | 484K | 681K | |||||
Net Income - (IS) | 13.77M | 33.04M | 52.06M | 11.64M | 38.46M | |||||
Net Income to Common Incl Extra Items | 13.77M | 33.04M | 52.06M | 11.64M | 38.46M | |||||
Net Income to Common Excl. Extra Items | 13.77M | 33.04M | 52.06M | 11.64M | 38.46M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.7 | 1.7 | 2.75 | 0.65 | 2.19 | |||||
Basic EPS - Continuing Operations | 0.7 | 1.7 | 2.75 | 0.65 | 2.19 | |||||
Basic Weighted Average Shares Outstanding | 19.63M | 19.4M | 18.92M | 17.9M | 17.58M | |||||
Net EPS - Diluted | 0.69 | 1.67 | 2.52 | 0.64 | 2.01 | |||||
Diluted EPS - Continuing Operations | 0.69 | 1.67 | 2.52 | 0.64 | 2.01 | |||||
Diluted Weighted Average Shares Outstanding | 20.04M | 19.73M | 22.38M | 18.06M | 20.47M | |||||
Normalized Basic EPS | 1.23 | 1.5 | 2.42 | 2.13 | 2.47 | |||||
Normalized Diluted EPS | 1.21 | 1.48 | 2.04 | 2.11 | 2.12 | |||||
Dividend Per Share | 0.18 | 0.2 | 0.22 | 0.24 | 0.26 | |||||
Payout Ratio | 25.64 | 11.51 | 7.87 | 36.51 | 11.69 | |||||
Supplemental Items | ||||||||||
EBITDA | 57.51M | 71.71M | 97.4M | 85.06M | 90.66M | |||||
EBITA | 54.87M | 68.47M | 94.3M | 81.67M | 87.4M | |||||
EBIT | 53.42M | 66.69M | 92.39M | 79.76M | 84.31M | |||||
EBITDAR | 61.86M | 75.61M | 102M | 89.56M | 94.37M | |||||
Effective Tax Rate - (Ratio) | 12.92 | 23.26 | 21.5 | 30.29 | 38.75 | |||||
Current Domestic Taxes | 6.26M | 7.22M | 15.52M | 11.27M | 16.89M | |||||
Current Foreign Taxes | - | - | - | 83K | -16K | |||||
Total Current Taxes | 6.26M | 7.22M | 15.52M | 11.36M | 16.88M | |||||
Deferred Domestic Taxes | -4.22M | 2.8M | -1.22M | -6M | 6.26M | |||||
Deferred Foreign Taxes | - | - | -265K | -502K | 767K | |||||
Total Deferred Taxes | -4.22M | 2.8M | -1.48M | -6.51M | 7.02M | |||||
Normalized Net Income | 24.2M | 29.16M | 45.73M | 38.13M | 43.49M | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Non-Cash Pension Expense | 22K | 1.12M | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 12M | 5.2M | 12.1M | 9.3M | 9.2M | |||||
Selling and Marketing Expenses | 18.1M | 22.8M | 27.6M | 24.2M | 23.5M | |||||
Research And Development Expense From Footnotes | 2.5M | 1.3M | 1.1M | 600K | 600K | |||||
Net Rental Expense, Total | 4.35M | 3.91M | 5.08M | 4.5M | 3.7M | |||||
Imputed Operating Lease Interest Expense | 2.31M | 2.06M | 2.17M | 1.65M | 1.17M | |||||
Imputed Operating Lease Depreciation | 2.03M | 1.84M | 2.91M | 2.85M | 2.53M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | 2.55M | 7.56M | 5.27M | 6.56M | |||||
Stock-Based Comp., Other (Total) | 3.63M | - | - | - | - | |||||
Total Stock-Based Compensation | 3.63M | 2.55M | 7.56M | 5.27M | 6.56M |